I’ve been thinking about this a lot lately. I’ve concluded that when I do give extra scrutiny to fields, it’s because I’m privellaging a hypothesis and/or wishfully thinking. For instance, I would like a vaccine for the common cold. I mean, it may not kill lots of people, but the shear incidence and malaise reduces a significant amount of quality of life. The prevalence in the Western World, and exposure to very powerful people would, I thought, mean significant interest in devleoping something. But people seem to take it for granted. Nobody seems to give a shit, in short.
Contrary to what the Wikipedia article might suggest, developing a cross-serotype vaccine for the common cold is intractable extensive computational advances based on my reading of this article. It does suggest that one approach branch was abandoned without rigorous statistical analyses, where that might be indicated, in this paper. Thought I don’t know how to interpet the table in question possibly because it’s design is idiosycratic to molecular biologists and I have a different education. I would like at it further, if I let my mistrust run wild, or ask ya’ll to look it. But really, the more parsimonious question was *why am I privileging that hypothesis?
For this specific question, it might be worth studying people (especially young people) who get fewer or no colds. It’s young people because I have heard that as you get older, your immune system develops a better library of cold viruses to fight off. This matches my experience, though I’ll also note that I get the same cold (or at least colds with the same symptoms) a number of times.
In general, I don’t think healthy people get studied enough.
I’ve been thinking about this a lot lately. I’ve concluded that when I do give extra scrutiny to fields, it’s because I’m privellaging a hypothesis and/or wishfully thinking. For instance, I would like a vaccine for the common cold. I mean, it may not kill lots of people, but the shear incidence and malaise reduces a significant amount of quality of life. The prevalence in the Western World, and exposure to very powerful people would, I thought, mean significant interest in devleoping something. But people seem to take it for granted. Nobody seems to give a shit, in short.
Contrary to what the Wikipedia article might suggest, developing a cross-serotype vaccine for the common cold is intractable extensive computational advances based on my reading of this article. It does suggest that one approach branch was abandoned without rigorous statistical analyses, where that might be indicated, in this paper. Thought I don’t know how to interpet the table in question possibly because it’s design is idiosycratic to molecular biologists and I have a different education. I would like at it further, if I let my mistrust run wild, or ask ya’ll to look it. But really, the more parsimonious question was *why am I privileging that hypothesis?
For this specific question, it might be worth studying people (especially young people) who get fewer or no colds. It’s young people because I have heard that as you get older, your immune system develops a better library of cold viruses to fight off. This matches my experience, though I’ll also note that I get the same cold (or at least colds with the same symptoms) a number of times.
In general, I don’t think healthy people get studied enough.